Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab in SLE (EMBLEM)
NCT00624351Phase 2Completed
- Sponsor
- UCB
- Start
- Jan 2008
- Primary completion
- Aug 2009
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of epratuzumab in systemic lupus erythematosus (SLE), sponsored by UCB. Started Jan 2008; status: completed.
02
Drugs
epratuzumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00624351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624351.